Paul A. Luciw
About
Paul A. Luciw is a scholar working on Virology, Infectious Diseases and Epidemiology.
According to data from OpenAlex, Paul A. Luciw has authored 200 papers receiving a total of 14.3k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Virology, 78 papers in Infectious Diseases and 77 papers in Epidemiology. Recurrent topics in Paul A. Luciw's work include HIV Research and Treatment (127 papers), HIV/AIDS drug development and treatment (46 papers) and Herpesvirus Infections and Treatments (43 papers). Paul A. Luciw is often cited by papers focused on HIV Research and Treatment (127 papers), HIV/AIDS drug development and treatment (46 papers) and Herpesvirus Infections and Treatments (43 papers). Paul A. Luciw collaborates with scholars based in United States, France and Pakistan. Paul A. Luciw's co-authors include B. Matija Peterlin, Jay A. Levy, Harold Varmus, Cecilia Cheng‐Mayer, Michael D. Power, Katherine A. Jones, Philip J. Barr, B. Matija Peterlin, Shaw-Yi Kao and Andrew F. Calman and has published in prestigious journals such as Nature, Science and Cell.
In The Last Decade
Paul A. Luciw
199 papers receiving 13.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Paul A. Luciw United States | 63 | 8.1k | 4.5k | 4.4k | 4.2k | 4.0k | 200 | 14.3k | ||
| Dani P. Bolognesi United States | 53 | 7.5k 0.9× | 4.0k 0.9× | 3.0k 0.7× | 5.3k 1.2× | 4.3k 1.1× | 175 | 13.5k | ||
| George N. Pavlakis United States | 71 | 6.0k 0.7× | 7.7k 1.7× | 2.4k 0.5× | 3.1k 0.7× | 6.0k 1.5× | 248 | 16.3k | ||
| Malcolm A. Martin United States | 50 | 8.6k 1.1× | 3.3k 0.7× | 2.7k 0.6× | 4.6k 1.1× | 3.9k 1.0× | 108 | 12.3k | ||
| Mariano Estéban Spain | 67 | 5.8k 0.7× | 5.7k 1.3× | 5.7k 1.3× | 2.6k 0.6× | 5.4k 1.3× | 366 | 15.8k | ||
| Paul D. Bieniasz United States | 78 | 10.6k 1.3× | 7.1k 1.6× | 6.0k 1.4× | 6.7k 1.6× | 7.1k 1.8× | 183 | 21.0k | ||
| Thomas J. Hope United States | 59 | 5.6k 0.7× | 5.9k 1.3× | 2.5k 0.6× | 3.2k 0.8× | 3.4k 0.8× | 206 | 13.2k | ||
| David B. Weiner United States | 77 | 5.2k 0.6× | 8.2k 1.8× | 4.6k 1.0× | 4.8k 1.1× | 10.8k 2.7× | 483 | 22.1k | ||
| Lee Ratner United States | 64 | 8.6k 1.1× | 4.9k 1.1× | 2.4k 0.6× | 5.4k 1.3× | 7.1k 1.8× | 300 | 17.5k | ||
| Olivier Schwartz France | 74 | 8.8k 1.1× | 4.6k 1.0× | 4.1k 0.9× | 6.6k 1.6× | 9.6k 2.4× | 241 | 19.7k | ||
| Norman L. Letvin United States | 84 | 13.8k 1.7× | 4.6k 1.0× | 6.7k 1.5× | 6.1k 1.4× | 15.1k 3.8× | 410 | 25.1k |
Countries citing papers authored by Paul A. Luciw
Since
Specialization
Citations
This map shows the geographic impact of Paul A. Luciw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Luciw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Luciw more than expected).
Fields of papers citing papers by Paul A. Luciw
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Paul A. Luciw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Luciw. The network helps show where Paul A. Luciw may publish in the future.
Co-authorship network of co-authors of Paul A. Luciw
This figure shows the co-authorship network connecting the top 25 collaborators of Paul A. Luciw. A scholar is included among the top collaborators of Paul A. Luciw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul A. Luciw. Paul A. Luciw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Ravindran, Resmi, Ellen O’Connor, Ajay Gupta, et al.. (2023). Lipid Mediators and Cytokines/Chemokines Display Differential Profiles in Severe versus Mild/Moderate COVID-19 Patients. International Journal of Molecular Sciences. 24(17). 13054–13054.
2.
Rosen, Elias P., Martina Kovářová, Leila Remling‐Mulder, et al.. (2018). Antiretroviral concentrations and surrogate measures of efficacy in the brain tissue and CSF of preclinical species. Xenobiotica. 49(10). 1192–1201.
3.
Chromy, Brett A., Angela Eldridge, Jonathan A. Forsberg, et al.. (2013). Wound outcome in combat injuries is associated with a unique set of protein biomarkers. Journal of Translational Medicine. 11(1). 281–281.
4.
Shahzad, Mirza Imran, Imran Khan, Paul A. Luciw, Muhammad Gulfraz, & Azra Khanum. (2013). Cloning, expression and genetic immunization studies of Mycobacterium tuberculosis gene esat6. Pakistan Journal of Zoology. 45(3). 749–757.
5.
Chu, Hiutung, Timothy L. Hayes, Paul A. Luciw, et al.. (2012). Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection. BMC Complementary and Alternative Medicine. 12(1).
6.
Saqib, Muhammad Arif Nadeem, Mirza Imran Shahzad, Aamer Ali Khattak, et al.. (2012). Expression and Purification of Mycobacterium tuberculosis Antigens for Use in Immunoassays for Serodetection of M. tuberculosis Infection in TB Patients. Pakistan Journal of Zoology. 44(1). 217–226.
7.
Luciw, Paul A., Karen Oslund, Lourdes Adamson, et al.. (2011). Stereological analysis of bacterial load and lung lesions in nonhuman primates (rhesus macaques) experimentally infected with Mycobacterium tuberculosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 301(5). L731–L738.
8.
Campbell, Mel, Wen‐Rong Lie, Jing Zhao, et al.. (2010). Multiplex Analysis of Src Family Kinase Signaling by Microbead Suspension Arrays. Assay and Drug Development Technologies. 8(4). 488–496.
9.
Khan, Imran, Jing Zhao, P. Ghosh, et al.. (2009). Microbead Arrays for the Analysis of ErbB Receptor Tyrosine Kinase Activation and Dimerization in Breast Cancer Cells. Assay and Drug Development Technologies. 8(1). 27–36.
10.
Marecki, John C., Carlyne D. Cool, Jane E. Parr, et al.. (2006). HIV-1 Nef Is Associated with Complex Pulmonary Vascular Lesions in SHIV- nef –infected Macaques. American Journal of Respiratory and Critical Care Medicine. 174(4). 437–445.
11.
Gupta, Soumi, Fengmin Zhou, Catherine E. Greer, et al.. (2006). Antibody Responses against HIV in Rhesus Macaques following Combinations of Mucosal and Systemic Immunizations with Chimeric Alphavirus-Based Replicon Particles. AIDS Research and Human Retroviruses. 22(10). 993–997.
12.
Vajdy, Michael, Manmohan Singh, Jina Kazzaz, et al.. (2004). Mucosal and Systemic Anti-HIV Responses in Rhesus Macaques following Combinations of Intranasal and Parenteral Immunizations. AIDS Research and Human Retroviruses. 20(11). 1269–1281.
13.
Leutenegger, Christian M., Joanne Higgins, Alice F. Tarantal, et al.. (2001). Real-Time TaqMan PCR as a Specific and More Sensitive Alternative to the Branched-Chain DNA Assay for Quantitation of Simian Immunodeficiency Virus RNA. AIDS Research and Human Retroviruses. 17(3). 243–251.
14.
Harouse, Janet M., Rei Chin How Tan, Agegnehu Gettie, et al.. (1998). Mucosal Transmission of Pathogenic CXCR4-Utilizing SHIVSF33AVariants in Rhesus Macaques. Virology. 248(1). 95–107.
15.
Ahmad, Shabbir, Barbara L. Lohman, Marta L. Marthas, et al.. (1994). Reduced Virus Load in Rhesus Macaques Immunized with Recombinant gp160 and Challenged with Simian Immunodeficiency Virus. AIDS Research and Human Retroviruses. 10(2). 195–204.
16.
Luciw, Paul A., Kirsten E. Shaw, Ronald E. Unger, et al.. (1992). Genetic and Biological Comparisons of Pathogenic and Nonpathogenic Molecular Clones of Simian Immunodeficiency Virus (SIV MAC ). AIDS Research and Human Retroviruses. 8(3). 395–402.
17.
Gardner, M B, Janet K. Yamamoto, Marta L. Marthas, et al.. (1992). SIV and FIV Vaccine Studies at UC Davis: 1991 Update. AIDS Research and Human Retroviruses. 8(8). 1495–1498.
18.
Torres, José V., Nicolas Lévy, Vicente Planelles, et al.. (1991). Characterization of Rhesus Macaque B-Lymphoblastoid Cell Lines Infected with Simian Type D Retrovirus. AIDS Research and Human Retroviruses. 7(11). 899–909.
19.
Planelles, Vicente, Nancy L. Haigwood, Marta L. Marthas, et al.. (1991). Functional and Immunological Characterization of SIV Envelope Glycoprotein Produced in Genetically Engineered Mammalian Cells. AIDS Research and Human Retroviruses. 7(11). 889–898.
20.
Carlson, James R., JoAnn L. Yee, Alan Rosenthal, et al.. (1990). Vaccine Protection of Rhesus Macaques Against Simian Immunodeficiency Virus Infection. AIDS Research and Human Retroviruses. 6(11). 1239–1246.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Dani P. Bolognesi Breakdown of academic impact, for papers by George N. Pavlakis Breakdown of academic impact, for papers by Malcolm A. Martin Breakdown of academic impact, for papers by Mariano Estéban Breakdown of academic impact, for papers by Paul D. Bieniasz Breakdown of academic impact, for papers by Thomas J. Hope Breakdown of academic impact, for papers by David B. Weiner Breakdown of academic impact, for papers by Lee Ratner Breakdown of academic impact, for papers by Olivier Schwartz Breakdown of academic impact, for papers by Norman L. Letvin